- Citations, last 5 years
- 61
- Works, last 5 years
- 37
- h-index
- 17
- Scientists listed
- 1
- Grants since 2016
- 9
Grants received
2023–2026 · research · R44
Evaluation of anti-fibrotic and anti-inflammatory semi-synthetic oxysterol, Oxy210, as a therapeutic drug candidate for non-alcoholic steatohepatitis
Farhad Parhami · Max Biopharma (United States) · funded by National Institutes of Health
2023–2025 · research · R44
Evaluation of anti-fibrotic and anti-inflammatory semi-synthetic oxysterol, Oxy210, as a therapeutic drug candidate for non-alcoholic steatohepatitis
Farhad Parhami · Max Biopharma (United States) · funded by National Institutes of Health
2022–2024 · research · R43
An oxysterol drug candidate, Oxy210, for inhibition of pulmonary fibrosis through targeting hedgehog and TGFβ signaling
Farhad Parhami · Max Biopharma (United States) · funded by National Institutes of Health
2022–2024 · research · R43
Effect of a semi-synthetic oxysterol drug candidate, Oxy210, on atherosclerosis in a mouse model of NASH
Farhad Parhami · Max Biopharma (United States) · funded by National Institutes of Health
2021–2024 · research · R44
Therapeutic Development of Osteogenic Oxysterol, Oxy133, for Spine Fusion
Farhad Parhami · Max Biopharma (United States) · funded by National Institutes of Health
2021–2023 · research · R44
Therapeutic Development of Osteogenic Oxysterol, Oxy133, for Spine Fusion
Farhad Parhami · Max Biopharma (United States) · funded by National Institutes of Health
2020–2022 · research · R43
Inhibition of Liver Fibrosis by Oxysterol Drug Candidates in a Mouse Model of NASH
Farhad Parhami · Max Biopharma (United States) · funded by National Institutes of Health
2013–2020 · research · R44
Preclinical Development of Oxy200 for the Treatment of Osteoporosis
Frank Stappenbeck · Max Biopharma (United States) · funded by National Institutes of Health
2013–2021 · research · R44
Preclinical Development of Oxy200 for the Treatment of Osteoporosis
Frank Stappenbeck · Max Biopharma (United States) · funded by National Institutes of Health
